U.S. Food and Drug Administration Extends Use of Appian BPM
Appian Named Business Process Management Vendor of Choice Under immixGroup Contract
RESTON, VA & MCLEAN, VA - September 27, 2010—Appian, the global innovator in enterprise and on-demand business process management (BPM) technology, and immixGroup, a leading provider of technology products and services to the public sector, today announced that the U.S. Food and Drug Administration (FDA) has extended its use of the Appian BPM Suite. FDA has chosen Appian as its BPM vendor of choice under a new five-year Blanket Purchase Agreement (BPA) with immixGroup. With all options, the contract value exceeds $12M.
Initially, the FDA conducted a competitive review and acquisition process to select a commercial Business Process Management System (BPMS) for a pilot program. Appian was selected for the pilot. As a result of the success of that program, the FDA extended the Appian platform, including technology licenses and support services, to four BPM projects. The new BPA is based on the success of those previous projects. Appian partnered with immixGroup to provide the BPA under immixGroup’s GSA Schedule.
Appian expects all FDA Centers will utilize the BPM platform as the FDA executes on its goal to better streamline and manage its core business processes. The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.
“The extension of our relationship with FDA strengthens Appian’s leadership position in BPM for the federal government,” said Matthew Calkins, president and CEO of Appian. “The federal market is the largest adopter of BPM technology because government agencies understand that the efficiency, transparency, accountability and collaboration benefits of BPM directly support the current administration’s mandates for how government needs to operate.”
“immixGroup is focused on bridging the gap between government and technology vendors, making leading commercial technology more accessible to the public sector,” said Art Richer, president of immixGroup. “This BPA makes it easier than ever before for FDA customers to acquire the Appian BPM technology they need to accomplish their missions.”
About Appian
Appian is the global innovator in enterprise and on-demand business process management (BPM). Appian provides the fastest way to deploy robust processes, collapsing time to value for new process initiatives. Businesses and governments worldwide use Appian to accelerate process improvement and drive business performance. Appian empowers more than 2.5 million users from large Fortune 100 companies, to the mid-market and small businesses worldwide. Appian is headquartered in the Washington, D.C. region, with professional services and partners around the globe. For more information, visit www.appian.com.